By indication / Pancreatic beta-cell imaging
Pancreatic beta-cell imaging
5 imaging agents and 4 therapeutic agents reported for this indication. Stage reflects how far each has been taken, not what is available in any given country.
Imaging
| Agent | Isotope | Stage | Syntheses |
|---|---|---|---|
| [68Ga]Ga-NODAGA-exendin-4 | Ga-68 | — | 23 |
| [68Ga]Ga-DOTA-exendin-4 paired with [177Lu]Lu-DOTA-exendin-4 | Ga-68 | — | 3 |
| [18F]FB(ePEG12)12-exendin-4 | F-18 | Phase 1 clinical study (first-in-human) | 2 |
| [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 | Ga-68 | — | 2 |
| [18F]FDDNP | F-18 | — | 1 |
Therapy
| Agent | Isotope | Stage | Syntheses |
|---|---|---|---|
| [68Ga]NOTA-MI-exendin-4 | Ga-68 | Reported once | 2 |
| [125I]I-Ex-D3 | I-125 | Reported once | 1 |
| [125I]I-Ex-4 | I-125 | Reported once | 1 |
| [177Lu]Lu-DOTA-MI-exendin-4 | Lu-177 | Reported once | 1 |
Have a question?Reagents, modules, introductions to manufacturers or to specialists in your region — tell us what you need.
Get in touch